Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ERDÖS EG[au]:

Cellular carboxypeptidases. Skidgel RA et al. Immunol Rev. (1998)

Kinin- and angiotensin-converting enzyme (ACE) inhibitor-mediated nitric oxide production in endothelial cells. Skidgel RA et al. Biol Chem. (2006)

The kinins. A status report. Erdös EG et al. Biochem Pharmacol. (1976)

Search results

Items: 1 to 50 of 211

1.

Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function.

Erdös EG, Tan F, Skidgel RA.

Hypertension. 2010 Feb;55(2):214-20. doi: 10.1161/HYPERTENSIONAHA.109.144600. Epub 2010 Jan 11. Review.

2.

Regarding "German science and black racism--roots of the Nazi Holocaust".

Erdös EG.

FASEB J. 2008 Jun;22(6):1623; author reply 1623-4. doi: 10.1096/fj.08-0602ltr. No abstract available.

PMID:
18519806
3.

Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator.

Skidgel RA, Erdös EG.

Int Immunopharmacol. 2007 Dec 20;7(14):1888-99. Epub 2007 Aug 15. Review.

4.

Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain.

Keil C, Maskos K, Than M, Hoopes JT, Huber R, Tan F, Deddish PA, Erdös EG, Skidgel RA, Bode W.

J Mol Biol. 2007 Feb 16;366(2):504-16. Epub 2006 Nov 11.

PMID:
17157876
5.

Human ACE and bradykinin B2 receptors form a complex at the plasma membrane.

Chen Z, Deddish PA, Minshall RD, Becker RP, Erdös EG, Tan F.

FASEB J. 2006 Nov;20(13):2261-70.

6.

The ACE and I: how ACE inhibitors came to be.

Erdös EG.

FASEB J. 2006 Jun;20(8):1034-8. No abstract available.

PMID:
16770001
7.

Kinin- and angiotensin-converting enzyme (ACE) inhibitor-mediated nitric oxide production in endothelial cells.

Skidgel RA, Stanisavljevic S, Erdös EG.

Biol Chem. 2006 Feb;387(2):159-65. Review.

PMID:
16497147
8.

Angiotensin I-converting enzyme inhibitors block protein kinase C epsilon by activating bradykinin B1 receptors in human endothelial cells.

Stanisavljevic S, Ignjatovic T, Deddish PA, Brovkovych V, Zhang K, Erdös EG, Skidgel RA.

J Pharmacol Exp Ther. 2006 Mar;316(3):1153-8. Epub 2005 Nov 10.

PMID:
16282523
9.

Kallikrein activates bradykinin B2 receptors in absence of kininogen.

Biyashev D, Tan F, Chen Z, Zhang K, Deddish PA, Erdös EG, Hecquet C.

Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H1244-50. Epub 2005 Nov 4.

10.

Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors.

Chen Z, Tan F, Erdös EG, Deddish PA.

Hypertension. 2005 Dec;46(6):1368-73. Epub 2005 Oct 24.

11.

Positive cooperativity between the thrombin and bradykinin B2 receptors enhances arachidonic acid release.

Hecquet C, Biyashev D, Tan F, Erdös EG.

Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H948-58. Epub 2005 Sep 23.

12.

Plasmin alters the activity and quaternary structure of human plasma carboxypeptidase N.

Quagraine MO, Tan F, Tamei H, Erdös EG, Skidgel RA.

Biochem J. 2005 May 15;388(Pt 1):81-91.

13.

Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands.

Ignjatovic T, Stanisavljevic S, Brovkovych V, Skidgel RA, Erdös EG.

Mol Pharmacol. 2004 Nov;66(5):1310-6. Epub 2004 Aug 10.

PMID:
15304551
15.

The discovery of captopril: reply.

Erdös EG.

FASEB J. 2004 Feb;18(2):226. No abstract available.

PMID:
14769816
16.

B2R of bradykinin activated by proteases.

Deddish PA, Hecquet C, Erdös EG.

Hypertension. 2003 Aug;42(2):e1-2; author reply e1-2. Epub 2003 Jun 30. No abstract available.

PMID:
12835333
17.

Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin.

Erdös EG, Jackman HL, Brovkovych V, Tan F, Deddish PA.

J Mol Cell Cardiol. 2002 Dec;34(12):1569-76. Review.

PMID:
12505055
18.

Kallikreins when activating bradykinin B2 receptor induce its redistribution on plasma membrane.

Hecquet C, Becker RP, Tan F, Erdös EG.

Int Immunopharmacol. 2002 Dec;2(13-14):1795-806.

PMID:
12489794
19.

Activation of bradykinin B1 receptor by ACE inhibitors.

Ignjatovic T, Tan F, Brovkovych V, Skidgel RA, Erdös EG.

Int Immunopharmacol. 2002 Dec;2(13-14):1787-93. Review.

PMID:
12489793
20.

The kinin system: suggestions to broaden some prevailing concepts.

Erdös EG, Deddish PA.

Int Immunopharmacol. 2002 Dec;2(13-14):1741-6. Review.

PMID:
12489787
21.

Kinins, the long march--a personal view.

Erdös EG.

Cardiovasc Res. 2002 Jun;54(3):485-91. Review. No abstract available.

PMID:
12031692
22.

Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A.

Jackman HL, Massad MG, Sekosan M, Tan F, Brovkovych V, Marcic BM, Erdös EG.

Hypertension. 2002 May;39(5):976-81.

PMID:
12019279
23.

Neprilysin inhibitors potentiate effects of bradykinin on b2 receptor.

Deddish PA, Marcic BM, Tan F, Jackman HL, Chen Z, Erdös EG.

Hypertension. 2002 Feb;39(2 Pt 2):619-23.

PMID:
11882619
24.

Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor.

Ignjatovic T, Tan F, Brovkovych V, Skidgel RA, Erdös EG.

J Biol Chem. 2002 May 10;277(19):16847-52. Epub 2002 Mar 5.

25.

Kinins, receptors, kininases and inhibitors--where did they lead us?

Erdös EG, Marcic BM.

Biol Chem. 2001 Jan;382(1):43-7. Review.

PMID:
11258670
26.

Potentiation of the effects of bradykinin on its receptor in the isolated guinea pig ileum.

Minshall RD, Nedumgottil SJ, Igić R, Erdös EG, Rabito SF.

Peptides. 2000 Aug;21(8):1257-64.

PMID:
11035213
27.

Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases.

Hecquet C, Tan F, Marcic BM, Erdös EG.

Mol Pharmacol. 2000 Oct;58(4):828-36.

PMID:
10999954
28.

Effects of the N-terminal sequence of ACE on the properties of its C-domain.

Marcic B, Deddish PA, Jackman HL, Erdös EG, Tan F.

Hypertension. 2000 Jul;36(1):116-21.

PMID:
10904022
31.

Potentiation of Bradykinin Actions by ACE Inhibitors.

Erdös EG, Deddish PA, Marcic BM.

Trends Endocrinol Metab. 1999 Aug;10(6):223-229.

PMID:
10407396
32.

Enhancement of bradykinin and resensitization of its B2 receptor.

Marcic B, Deddish PA, Jackman HL, Erdös EG.

Hypertension. 1999 Mar;33(3):835-43.

PMID:
10082496
33.

Cellular carboxypeptidases.

Skidgel RA, Erdös EG.

Immunol Rev. 1998 Feb;161:129-41. Review.

PMID:
9553770
34.

N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.

Deddish PA, Marcic B, Jackman HL, Wang HZ, Skidgel RA, Erdös EG.

Hypertension. 1998 Apr;31(4):912-7.

PMID:
9535414
35.

Detection of neutral endopeptidase 24.11 (neprilysin) in human hepatocellular carcinomas by immunocytochemistry.

Dragovic T, Sekosan M, Becker RP, Erdös EG.

Anticancer Res. 1997 Sep-Oct;17(5A):3233-8.

PMID:
9413153
36.

Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells.

Minshall RD, Tan F, Nakamura F, Rabito SF, Becker RP, Marcic B, Erdös EG.

Circ Res. 1997 Nov;81(5):848-56. Erratum in: Circ Res 1998 Jan 9-23;82(1):137.

PMID:
9351459
37.
38.

Differences in the hydrolysis of enkephalin congeners by the two domains of angiotensin converting enzyme.

Deddish PA, Jackman HL, Skidgel RA, Erdös EG.

Biochem Pharmacol. 1997 May 15;53(10):1459-63.

PMID:
9260873
39.

Single-domain angiotensin I converting enzyme (kininase II): characterization and properties.

Deddish PA, Wang LX, Jackman HL, Michel B, Wang J, Skidgel RA, Erdös EG.

J Pharmacol Exp Ther. 1996 Dec;279(3):1582-9.

PMID:
8968386
40.

Removal of Arg141 from the alpha chain of human hemoglobin by carboxypeptidases N and M.

Michel B, Igić R, Leray V, Deddish PA, Erdös EG.

Circ Res. 1996 Apr;78(4):635-42.

PMID:
8635221
41.

News about ACE, or, the separate lives of "Siamese twin" domains.

Erdös EG.

J Clin Invest. 1996 Feb 1;97(3):588. No abstract available.

42.

Kininase II-type enzymes. Their putative role in muscle energy metabolism.

Dragović T, Minshall R, Jackman HL, Wang LX, Erdös EG.

Diabetes. 1996 Jan;45 Suppl 1:S34-7.

PMID:
8529798
43.

Expression of rat kallikrein and epithelial polarity in transfected Madin-Darby canine kidney cells.

Abe M, Nakamura F, Tan F, Deddish PA, Colley KJ, Becker RP, Skidgel RA, Erdös EG.

Hypertension. 1995 Dec;26(6 Pt 1):891-8.

PMID:
7490145
44.

More on subforms of creatine kinase MB.

Erdös EG, Skidgel RA.

N Engl J Med. 1995 Aug 10;333(6):390. No abstract available.

PMID:
7609766
45.

Carboxypeptidase M activity is increased in bronchoalveolar lavage in human lung disease.

Dragović T, Schraufnagel DE, Becker RP, Sekosan M, Votta-Velis EG, Erdös EG.

Am J Respir Crit Care Med. 1995 Aug;152(2):760-4.

PMID:
7633739
46.

Plasma membrane-bound and lysosomal peptidases in human alveolar macrophages.

Jackman HL, Tan F, Schraufnagel D, Dragović T, Dezsö B, Becker RP, Erdös EG.

Am J Respir Cell Mol Biol. 1995 Aug;13(2):196-204.

PMID:
7626287
47.

Naturally occurring active N-domain of human angiotensin I-converting enzyme.

Deddish PA, Wang J, Michel B, Morris PW, Davidson NO, Skidgel RA, Erdös EG.

Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7807-11.

48.

Importance of sympathetic innervation in the positive inotropic effects of bradykinin and ramiprilat.

Minshall RD, Yelamanchi VP, Djokovic A, Miletich DJ, Erdös EG, Rabito SF, Vogel SM.

Circ Res. 1994 Mar;74(3):441-7.

PMID:
8118952
49.

Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas.

Dragović T, Deddish PA, Tan F, Weber G, Erdös EG.

Lab Invest. 1994 Jan;70(1):107-13.

PMID:
8302012
50.

Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C). Similarity to both serine carboxypeptidase and prolylendopeptidase families.

Tan F, Morris PW, Skidgel RA, Erdös EG.

J Biol Chem. 1993 Aug 5;268(22):16631-8. Erratum in: J Biol Chem 1993 Dec 5;268(34):26032.

Supplemental Content

Loading ...
Support Center